ABBOTT LABORATORIES — Director's Dealing 2012

Apr 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-03-30

Reporting Person: Warmuth Michael J (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-30	Common shares without par value	M	4540	$54.03	Acquired	47826	Direct
2012-03-30	Common shares without par value	M	2649	$57.93	Acquired	50475	Direct
2012-03-30	Common shares without par value	M	6146	$54.05	Acquired	56621	Direct
2012-03-30	Common shares without par value	S	13335	$61.16	Disposed	43286	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-30	Option (right to buy)	$54.03	M	4540	Disposed	2013-02-13	Common shares (4540)	Direct
2012-03-30	Option (right to buy)	$57.93	M	2649	Disposed	2013-02-13	Common shares (2649)	Direct
2012-03-30	Option (right to buy)	$54.05	M	6146	Disposed	2013-02-13	Common shares (6146)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	25337	Indirect

Footnotes

F1: Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.